Zobair M. Younossi
0000-0001-9313-577X
Publication & Citation Trends
Publications
0 total
Improvement in health-related quality of life after treatment with resmetirom in patients with the spectrum of MASLD: From early MASH to MASH cirrhosis.
Cited by 1
Semantic Scholar
Cost of hepatic decompensation and liver transplantation events in primary biliary cholangitis: a retrospective observational study
Cited by 0
Semantic Scholar
Is liver steatosis a disease or the emperor's new clothes?
Cited by 2
Semantic Scholar
Binge drinking, metabolic dysfunction, and the spectrum of steatotic liver disease in the USA: a cross-sectional and longitudinal analysis
Cited by 1
Semantic Scholar
Pharmacotherapy for metabolic dysfunction-associated steatohepatitis: heart-liver co-management.
Cited by 1
Semantic Scholar
Impact of fibrotic MASH as a new indication on semaglutide eligibility in the U.S. adult population
Cited by 0
Semantic Scholar
Self-Reported Cognitive Function in MASLD and MASH: A Post-Hoc Analysis of the MAESTRO Resmetirom Trials
Cited by 0
Semantic Scholar
Clinical Outcomes and Non‐Invasive Testing in Metabolic Dysfunction‐Associated Steatohepatitis With Cirrhosis: A Systematic Review
Cited by 0
Semantic Scholar
Research Topics
Liver Disease Diagnosis and Treatment
(1140)
Hepatitis C virus research
(503)
Liver Disease and Transplantation
(412)
Diet, Metabolism, and Disease
(190)
Liver Diseases and Immunity
(175)
Affiliations
Goethe University Frankfurt
Inova Health System
Scripps Research Institute
George Washington University Hospital
MetroHealth